Beckman Coulter Life Sciences Acquires Flow Cytometry Firms Xitogen, Cytojene | GenomeWeb

NEW YORK (GenomeWeb) – Beckman Coulter Life Sciences today announced it is acquiring Chinese flow cytometry firms Xitogen Technologies and Cytojene for an undisclosed amount.

Based in Suzhou and Dalian, China, Xitogen provides Beckman Coulter an operational base in China and "a high quality research instrument" that rounds out Beckman Coulter's cytometry portfolio, the Danaher business said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.